SCHEMBL17875588

SCHEMBL17875588

Cc1ccc(N2COc3cc(C)ccc3C2)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 5/20 0.40
MCOLN3 Q8TDD5 1/20 0.38
HTT P42858 4/20 0.37
POLB P06746 2/20 0.37
HPGD P15428 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 5/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MAPK1 P28482 1/20 0.34
TSHR P16473 1/20 0.34
VDR P11473 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13309242 0.88 MAPT (0.47) MAPTSMN1; SMN2GAAALDH1A1MCOLN3
SCHEMBL22133009 0.85 MAPT (0.42) MAPTSMN1; SMN2GAAALDH1A1HTT
SCHEMBL17875594 0.82 MAPT (0.43) MAPTSMN1; SMN2GAAALDH1A1HTT
SCHEMBL17875596 0.79 MAPT (0.50) MAPTSMN1; SMN2GAAALDH1A1LMNA
SCHEMBL17703330 0.78 MAPT (0.39) MAPTSMN1; SMN2GAAALDH1A1MEN1
SCHEMBL22100181 0.77 MAPT (0.39) MAPTSMN1; SMN2GAAALDH1A1HTT
SCHEMBL15297298 0.77 VDR (0.56) MAPTSMN1; SMN2GAAALDH1A1MEN1
SCHEMBL17875590 0.75 MAPT (0.69) MAPTSMN1; SMN2GAAALDH1A1HTT
SCHEMBL17703324 0.72 VDR (0.45) MAPTSMN1; SMN2GAAALDH1A1HTT
SCHEMBL15307675 0.72 VDR (0.45) MAPTPOLBMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133556-A1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME CYTEC INDUSTRIES INC 2023-05-04 US disclosed
US-20230133556-A1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME CYTEC INDUSTRIES INC 2023-05-04 US disclosed
US-11566106-B2 Composite materials containing benzoxazines and method for making the same CYTEC INDUSTRIES INC. (US) 2023-01-31 US disclosed
US-20200291179-A1 COMPOSITE MATERIALS CONTAINING BENZOXAZINES AND METHOD FOR MAKING THE SAME CYTEC INDUSTRIES INC. (US) 2020-09-17 US disclosed
EP-3240829-B1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME CYTEC IND INC (US) 2019-08-21 EP disclosed
WO-2016109399-A1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME CYTEC INDUSTRIES INC. (US) 2016-07-07 WO disclosed
US-20160185908-A1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME CYTEC INDUSTRIES INC. (US) 2016-06-30 US disclosed
US-20160185908-A1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME CYTEC INDUSTRIES INC. (US) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291179-A1 COMPOSITE MATERIALS CONTAINING BENZOXAZINES AND METHOD FOR MAKING THE SAME F12, COL1A1, BRIX1 MAPT 2756/4885SMN1; SMN2 765/4885GAA 963/4885
US-11566106-B2 Composite materials containing benzoxazines and method for making the same F12, COL1A1, BRIX1 MAPT 2756/4885SMN1; SMN2 765/4885GAA 963/4885
US-20230133556-A1 BENZOXAZINES AND COMPOSITIONS CONTAINING THE SAME F12, BRIX1, COL1A1 MAPT 2194/4885SMN1; SMN2 985/4885GAA 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.